Table 25.2
Summary of novel biomarkers in acute and chronic heart failure
BiomarkerPlasma levels in ADHFIndependent prognostic information?Levels altered with therapy?Plasma levels in CHFIndependent prognostic information?Levels altered with therapy?

MR-proANP

Yes

U

Yes

U

MR-proADM

U

U

U

Yes

U

copeptin

Yes

U

Yes

U

Apelin

No

No

U

Yes

Urocortin

U

U

U

U

U

CgA

Yes

U

Yes

No

CoQ10

U

U

U

Yes

U

Adiponectin

Yes

U

Yes

U

H-FABP

U

U

U

Yes

Yes

MLC-1

U

U

U

Yes

U

Osteopontin

U

U

U

Yes

U

GDF-15

U

U

U

Yes

U

Pentraxin-3

U

U

U

Yes

U

Secretory sphingomyelinase

U

U

U

Yes

U

CT-1

U

U

U

Yes

U

Gal-3

Yes

U

U

No

ST2

Yes

U

Yes

U

Cystatin C

Yes

U

Yes

U

SP-B

U

Yes

U

Yes

BiomarkerPlasma levels in ADHFIndependent prognostic information?Levels altered with therapy?Plasma levels in CHFIndependent prognostic information?Levels altered with therapy?

MR-proANP

Yes

U

Yes

U

MR-proADM

U

U

U

Yes

U

copeptin

Yes

U

Yes

U

Apelin

No

No

U

Yes

Urocortin

U

U

U

U

U

CgA

Yes

U

Yes

No

CoQ10

U

U

U

Yes

U

Adiponectin

Yes

U

Yes

U

H-FABP

U

U

U

Yes

Yes

MLC-1

U

U

U

Yes

U

Osteopontin

U

U

U

Yes

U

GDF-15

U

U

U

Yes

U

Pentraxin-3

U

U

U

Yes

U

Secretory sphingomyelinase

U

U

U

Yes

U

CT-1

U

U

U

Yes

U

Gal-3

Yes

U

U

No

ST2

Yes

U

Yes

U

Cystatin C

Yes

U

Yes

U

SP-B

U

Yes

U

Yes

↑: raised; ↓: reduced; ↔: no change; ADHF; acutely decompensated heart failure; CHF, congestive heart failure; U, unknown.

Adapted from Dalzel JR et al. Biomark Med 2009;3(5):483–93.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close